Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04JYW
|
|||
| Former ID |
DNC013316
|
|||
| Drug Name |
(+/-)-oxiran-2-ylmethyl (9Z)-hexadec-9-enoate
|
|||
| Synonyms |
CHEMBL230968; 213738-77-3; SCHEMBL4979121; BDBM50220357; UCM710, > oxiran-2-ylmethyl (9z)-hexadec-9-enoate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H34O3
|
|||
| Canonical SMILES |
CCCCCCC=CCCCCCCCC(=O)OCC1CO1
|
|||
| InChI |
1S/C19H34O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(20)22-17-18-16-21-18/h7-8,18H,2-6,9-17H2,1H3/b8-7-
|
|||
| InChIKey |
FWEHVPCBXKCYHE-FPLPWBNLSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase. J Med Chem. 2007 Oct 4;50(20):5012-23. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.